These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7486949

  • 1. Suppression of infectious virus spread to the liver by foscarnet following lethal infection of acyclovir-resistant herpes simplex virus type 2 in mice.
    Li YY, Minagawa H, Tanaka S, Mori R.
    Antiviral Res; 1995 May; 27(1-2):111-21. PubMed ID: 7486949
    [Abstract] [Full Text] [Related]

  • 2. Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
    Safrin S, Kemmerly S, Plotkin B, Smith T, Weissbach N, De Veranez D, Phan LD, Cohn D.
    J Infect Dis; 1994 Jan; 169(1):193-6. PubMed ID: 8277181
    [Abstract] [Full Text] [Related]

  • 3. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
    Chibo D, Mijch A, Doherty R, Birch C.
    J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R, Andrei G, Gérard M, Silverman A, Hedderman A, Balzarini J, Sadzot-Delvaux C, Tricot G, Clumeck N, De Clercq E.
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
    Bernstein DI, Ireland J, Bourne N.
    Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
    [Abstract] [Full Text] [Related]

  • 6. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
    Safrin S, Elbeik T, Mills J.
    J Infect Dis; 1994 Apr; 169(4):879-82. PubMed ID: 8133105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J.
    N Engl J Med; 1991 Aug 22; 325(8):551-5. PubMed ID: 1649971
    [Abstract] [Full Text] [Related]

  • 9. Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).
    Arinze F, Shaver A, Raffanti S.
    Infection; 2017 Oct 22; 45(5):705-707. PubMed ID: 28508238
    [Abstract] [Full Text] [Related]

  • 10. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
    Gaudreau A, Hill E, Balfour HH, Erice A, Boivin G.
    J Infect Dis; 1998 Aug 22; 178(2):297-303. PubMed ID: 9697707
    [Abstract] [Full Text] [Related]

  • 11. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H, McMillan A, Darby G.
    J Infect Dis; 1981 Feb 22; 143(2):281-5. PubMed ID: 6260876
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M, Yasuda Y, Yabe H, Kato S, Suzutani T, De Clercq E, Niikura M, Maeda A, Kurane I, Morikawa S.
    J Med Virol; 2002 Sep 22; 68(1):99-104. PubMed ID: 12210436
    [Abstract] [Full Text] [Related]

  • 13. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M, Wunderli W, Trellu-Toutous L, Harms M, Saura JH, Krischer J.
    Dermatology; 1998 Sep 22; 197(3):278-80. PubMed ID: 9812037
    [Abstract] [Full Text] [Related]

  • 14. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C, Bianchi A.
    Pathol Biol (Paris); 1993 Feb 22; 41(2):172-7. PubMed ID: 8392160
    [Abstract] [Full Text] [Related]

  • 15. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
    Hardy WD.
    Am J Med; 1992 Feb 14; 92(2A):30S-35S. PubMed ID: 1531285
    [Abstract] [Full Text] [Related]

  • 16. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M, Okuda T, Shiraki K.
    Antiviral Res; 2006 Nov 14; 72(2):157-61. PubMed ID: 16797734
    [Abstract] [Full Text] [Related]

  • 17. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF, Cornelissen JJ, Smit J, Lepoutre J, de Gast GC, Dekker AW, Rozenberg-Arska M.
    Bone Marrow Transplant; 1993 Feb 14; 11(2):177-9. PubMed ID: 8382096
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
    Andrei G, Gillemot S, Topalis D, Snoeck R.
    J Infect Dis; 2018 Feb 14; 217(5):790-801. PubMed ID: 29186456
    [Abstract] [Full Text] [Related]

  • 20. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
    Marks GL, Nolan PE, Erlich KS, Ellis MN.
    Rev Infect Dis; 1989 Feb 14; 11(3):474-6. PubMed ID: 2546244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.